MRI features of benign multiple sclerosis Toward a new definition of this disease phenotype

Neurology

Volumn 72, Issue 19, 2009, Pages 1693-1701

  Rovaris, M ^a   Barkhof, F ^b   Calabrese, M ^c   De Stefano, N ^d   Fazekas, F ^e   Miller, D H ^f   Montalban, X ^g   Polman, C ^b   Rocca, M A ^h   Thompson, A J ^f   Yousry, T A ^f   Filippi, M ^h  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENIGN MULTIPLE SCLEROSIS; BRAIN INJURY; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 67049100681     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181a55feb     Document Type: Review

References (60)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2008; 372:1502-1517.
2. Lublin FD, Reingold SC, the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-911.
3. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
4. Bergamaschi R, Quaglini S, Trojano M, et al. Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score. J Neurol Neurosurg Psychiatry 2007;78:757-759.
5. Ramsaransing G, De Keyser J. Benign course in multiple sclerosis: a review. Acta Neurol Scand 2006;113:359-369.
6. Ramsaransing G, Maurits N, Zwanikken C, De Keyser J. Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review. Mult Scler 2001;7: 345-347.
7. Hawkins SA, Mc Donnell GV. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 1999; 67:148-152.
8. Pittock SJ, McClelland RL, Mayr WT, et al. Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol 2004;56: 303-306.
9. Sayao A-L, Devonshire V, Tremlett H. Longitudinal follow-up of "benign" multiple sclerosis at 20 years. Neurology 2007;68:496-500.
10. Costelloe L, Thompson A, Walsh C, Tubridy N, Hutchin-son M. Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease. J Neurol Neurosurg Psychiatry 2008;79:1245-1248.
11. Amato MP, Zipoli V, Goretti B, et al. Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol 2006;253:1054-1059.
12. Bakshi R, Thompson AJ, Rocca MA, et al. MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 2008:7:615-625.
13. Phadke JG, Best PV. Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy. J Neurol Neurosurg Psychiatry 1983;46:414-420.
14. Engell T. A clinical patho-anatomical study of clinically silent multiple sclerosis. Acta Neurol Scand 1989;79:428-430.
15. De Stefano N, Cocco E, Lai M, et al. Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis. Ann Neurol 2006;59:634-639.
16. Lebrun C, Bensa C, Debouverie M, et al. Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J Neurol Neurosurg Psychiatry 2008;79:195-198.
17. Filippi M, Iannucci G, Tortorella C, et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 1999;52:588-594.
18. Filippi M, Campi A, Martinelli V, Colombo B, Scotti G, Comi G. Brain and spinal cord MR in benign multiple sclerosis: a follow-up study. J Neurol Sci 1996;143:143-149.
19. Pittock SJ, Noseworthy JH, Rodriguez M. MRI findings in multiple sclerosis are variable. J Neurol 2007;254:539-541.
20. Koopmans RA, Li DK, Grochowski E, et al. Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features. Ann Neurol 1989;25:74-81.
21. Thompson AJ, Kermode AG, MacManus DG, et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. BMJ 1990;300:631-634.
22. Filippi M, Campi A, Mammi S, et al. Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1995;58:31-37.
23. Strasser-Fuchs S, Enzinger C, Ropele S, Wallner M, Faze-kas F. Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox? Mult Scler 2008; 14:205-211.
24. Fisniku LK, Brex PA, Altmann DR, et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008;131:808-817.
25. Goodin DS. Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment? Ann Neurol 2006; 59:597-605.
26. Calabrese M, Filippi M, Rovaris M, et al. Evidence for relative cortical sparing in benign MS: a longitudinal magnetic resonance imaging study. Mult Scler 2009;15:36-41.
27. Mesaros S, Rovaris M, Pagani E, et al. A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis. Arch Neurol 2008;65:1223-1230.
28. Bonek R, Orlicka K, Maciejek Z. Demyelinating lesions in the cervical cord in multiple sclerosis 10 years after onset of the disease: correlation between MRI parameters and clinical course. Neurol Neurochir Pol 2007;41:229-233.
29. Thompson AJ, Miller DH, Youl B, et al. Serial gadolinium-enhanced MRI in relapsing-remitting multiple sclerosis of varying disease duration. Neurology 1992; 42:60-62.
30. Filippi M, Capra R, Campi A, et al. Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;60:526-530.
31. Filippi M, Rovaris M, Capra R, et al. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis: implications for clinical trials. Brain 1998;121:2011-2020.
32. Silver NC, Good CD, Sormani MP, et al. A modified protocol to improve the detection of enhancing brain and spinal cord lesions in multiple sclerosis. J Neurol 2001;248: 215-224.
33. Minneboo A, Uitdehaag BM, Ader HJ, Barkhof F, Pol-man CH, Castelijns JA. Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients. Neurology 2005;65:56-61.
34. Traboulsee A, Dehmeshki J, Peters KR, et al. Disability in multiple sclerosis is related to normal appearing brain tissue abnormalities. Mult Scler 2003;9:566-573.
35. Ceccarelli A, Rocca MA, Pagani E, et al. The topographical distribution of tissue injury in benign MS: A 3T multipa-rametric study. Neuroimage 2008;39:1499-1509.
36. Rovaris M, Riccitelli G, Judica E, et al. Cognitive impairment and structural brain damage in benign multiple sclerosis. Neurology 2008;1521-1526.
37. Brass SD, Narayanan S, Antel JP, Lapierre Y, Collins L, Arnold DL. Axonal damage in multiple sclerosis patients with high versus low disability. Can J Neurol Sci 2004;31: 225-228.
38. Fisniku LK, Chard DT, Jackson JS, et al. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 2008;64:247-254.
39. Fisher E, Lee J, Nakamura K, Rudick RA. Gray matter atrophy and multiple sclerosis: a longitudinal study. Ann Neurol 2008;64:255-265.
40. Losseff N, Webb SL, O'Riordan JI, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression Brain 1996;119:701-708.
41. Filippi M, Campi A, Colombo B, et al. A spinal cord MRI study of benign and secondary progressive multiple sclerosis. J Neurol 1996:243:502-505.
42. Schmierer K, Scaravilli F, Altmann DR, Barker GJ, Miller DH. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004;56:407-415.
43. Rovaris M, Gass A, Bammer R, et al. Diffusion MRI in multiple sclerosis. Neurology 2005;65:1526-1532.
44. Bot JC, Blezer EL, Kamphorst W, et al. The spinal cord in multiple sclerosis: relationship of high spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology 2004;233:531-540.
45. Schmierer K, Wheeler-Kingshott CAM, Boulby PA, et al. Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage 2007;35:467-477.
46. Rocca MA, Colombo B, Falini A, et al. Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenorypes. Lancet Neurol 2005;4:618-626.
47. De Stefano N, Battaglini M, Stromillo ML, et al. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing MS. Brain 2006;129:2008-2016.
48. Dehmeshki J, Silver NC, Leary SM, Tofts PS, Thompson AJ, Miller DH. Magnetisation transfer ratio analysis of primary progressive and other multiple sclerosis subgroups. J Neurol Sci 2001;185:11-17.
49. Tortorella C, Viti B, Bozzali M, et al. A magnetization transfer histogram study of normal-appearing brain tissue in MS. Neurology 2000;54:186-193.
50. Filippi M, Inglese M, Rovaris M, et al. Magnetization transfer imaging to monitor the evolution of MS: a one-year follow up study. Neurology 2000;55:940-946.
51. Filippi M, Barker GJ, Horsfield MA, et al. Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study. J Neurol 1994;241:246-251.
52. Horsfield MA, Lai M, Webb SL, et al. Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance. Magn Reson Med 1996;36:393-400.
53. Droogan AG, Clark CA, Werring DJ, Barker GJ, McDonald WI, Miller DH. Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging. Magn Reson Imaging 1999;17:653-661.
54. Falini A, Calabrese G, Filippi M, et al. Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability. AJNR Am J Neuroradiol 1998; 19:223-229.
55. Davie CA, Silver NC, Barker GJ, et al. Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup? J Neurol Neurosurg Psychiatry 1999;67:710-715.
56. Benedetti B, Rovaris M, Rocca M, et al. Neuroaxonal brain viability does not differ between benign and early relapsing-remitting MS patients. Neurol Sci 2008;29(suppl):S196.
57. Benedetti B, Rovaris M, Pulizzi A, et al. A diffusion-tensor MRI study of the cervical cord damage in benign and secondary progressive MS patients. Neurology 2008;70(suppl 1): A471.
58. Amato MP, Portaccio E, Stromillo ML, et al. Cognitive assessment and quantitative MR metrics can help to identify benign multiple sclerosis. Neurology 2008;71:632-638.
59. Rocca MA, Falini A, Colombo B, Scotti G, Comi G, Filippi M. Adaptive functional changes in the cerebral cortex of patients with nondisabling MS correlate with the extent of brain structural damage. Ann Neurol 2002;51:330-339.
60. Rocca MA, Valsasina P, Ceccarelli A, et al. Structural and functional MRI correlates of Stroop control in benign MS. Hum Brain Mapp 2009;30:276-290.